In summary, this study systematically elucidates HL4’s cardioprotective mechanism via the STAT3/HIF-1α axis, providing a robust scientific foundation for its clinical application and laying groundwork for developing STAT3-targeted therapies for myocardial ischemia-reperfusion injury. The gene discussed is HIF1A; the disease is myocardial ischemia.